"Interventions to increase adherence to oral therapies in breast cancer patients: A systematic review based on the behavior change technique taxonomy".
behavior change technique taxonomy
cancer
decision-making
endocrine therapy
medication adherence
oncology
oral anticancer medications
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
29
06
2023
received:
20
01
2023
accepted:
28
07
2023
pubmed:
12
8
2023
medline:
12
8
2023
entrez:
12
8
2023
Statut:
ppublish
Résumé
High rates of non-adherence to oral medications in breast cancer (BC) patients have been reported. Here we provide an up-to-date systematic review of the interventions aimed at increasing adherence to oral medication in BC patients, with a particular focus on the content of the interventions. PubMed, Scopus, Embase and Ovid databases and reference lists of relevant studies were searched through October 2022. Studies which (1) described an intervention aimed at increasing adherence to oral anticancer medication, (2) included (or planned to include) at least one sub-group of BC patients, (3) were written in English, and (4) with full-text available were included. The contents of the interventions were coded using the Behavior Change Technique Taxonomy. Quality assessment was conducted using Downs and Black scale. Thirty-six studies met the inclusion criteria and involved a total sample of 28,528 BC patients. Interventions were mainly delivered with eHealth devices (n = 21) and most of them used mobile app. Other studies used in-person modalities (e.g., CBT, relaxation technique) or written materials (e.g., psycho-educational booklet). The behavior change techniques most frequently implemented were "problem solving," "social support," "information about health consequences," and "prompts/cues". Quality assessment revealed that the higher risk of bias refers to the selection process. The use of reminders, monitoring patients' medication-taking behaviors and giving feedback were the most frequently implemented techniques in those interventions that resulted significant. If these preliminary observations were to be confirmed by future comparative studies, they should be taken into account when developing new interventions.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1481-1502Subventions
Organisme : Pfizer
Informations de copyright
© 2023 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
Références
Rosenberg SM, Petrie KJ, Stanton AL, Ngo L, Finnerty E, Partridge AH. Interventions to enhance adherence to oral antineoplastic agents: a scoping review. J Natl Cancer Inst. 2020;112(5):443-465. https://doi.org/10.1093/jnci/djz244
Greer JA, Amoyal N, Nisotel L, et al. A systematic review of adherence to oral antineoplastic therapies. Oncol. 2016;21(3):354-376. https://doi.org/10.1634/theoncologist.2015-0405
Moon Z, Moss-Morris R, Hunter MS, Carlisle S, Hughes LD. Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Prefer Adherence. 2017;11:305-322. https://doi.org/10.2147/ppa.s126651
Yussof I, Mohd Tahir NA, Hatah E, Mohamed Shah N. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast. 2022;62:22-35. https://doi.org/10.1016/j.breast.2022.01.012
Brett J, Boulton M, Fenlon D, et al. Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence. Patient Prefer Adherence. 2018;12:291-300. https://doi.org/10.2147/PPA.S145784
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Heal. 2008;11(1):44-47. https://doi.org/10.1111/j.1524-4733.2007.00213.x
Finitsis DJ, Vose BA, Mahalak JG, Salner AL. Interventions to promote adherence to endocrine therapy among breast cancer survivors: a meta-analysis. Psycho Oncol. 2019;28(2):255-263. https://doi.org/10.1002/pon.4959
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21660
Cavazza M, Banks H, Ercolanoni M, et al. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management. Breast Cancer Res Treat. 2020;183(1):189-199. https://doi.org/10.1007/s10549-020-05748-6
Farias AJ, Wu W.-H, Du XL. Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: findings from TCR-Medicaid linked data. BMC Cancer. 2018;18(1):1214. https://doi.org/10.1186/s12885-018-5121-z
Lambert-Côté L, Bouhnik A.-D, Bendiane M.-K, et al. Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases. Breast Cancer Res Treat. 2020;180(3):777-790. https://doi.org/10.1007/s10549-020-05549-x
Inotai A, Ágh T, Maris R, et al. Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treat Rev. 2021;100:102264. https://doi.org/10.1016/j.ctrv.2021.102264
Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C. Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer. 2013;108(7):1515-1524. https://doi.org/10.1038/bjc.2013.116
Hershman DL, Shao T, Kushi LH, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529-537. https://doi.org/10.1007/s10549-010-1132-4
Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. https://doi.org/10.1136/bmjopen-2017-016982
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497. https://www.nejm.org/doi/10.1056/NEJMra050100
Gupta J, Joshi P, Kamra S, Sehgal M. Economic burden due to treatment non-adherence in patients with breast cancer: a systematic review. Value Heal. 2016;19(3):A156. https://doi.org/10.1016/j.jval.2016.03.1461
Chisholm-Burns MA, Spivey CA. The “cost” of medication nonadherence: consequences we cannot afford to accept. J Am Pharm Assoc. 2012;52(6):823-826. https://doi.org/10.1331/japha.2012.11088
Khan R, Socha-Dietrich K. Investing in medication adherence improves health outcomes and health system efficiency: adherence to medicines for diabetes, hypertension and hyperlipidaemia. OECD Heal Work Pap. 2018(105). [Internet]1,3-8,11-37. https://www.oecd-ilibrary.org/social-issues-migration-health/investing-in-medication-adherence-improves-health-outcomes-and-health-system-efficiency_8178962c-en
McCowan C, Wang S, Thompson AM, Makubate B, Petrie DJ. The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study. Br J Cancer. 2013;109(5):1172-1180. https://doi.org/10.1038/bjc.2013.464
Berkowitz MJ, Thompson CK, Zibecchi LT, et al. How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support. J Cancer Surviv. 2021;15(1):29-39. https://doi.org/10.1007/s11764-020-00908-5
da Costa DiBonaventura M, Copher R, Basurto E, Faria C, Lorenzo R. Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer. Am Heal Drug Benefits. 2014;7(7):386-396.
Hurtado-de-Mendoza A, Cabling ML, Lobo T, Dash C, Sheppard VB. Behavioral interventions to enhance adherence to hormone therapy in breast cancer survivors: a systematic literature review. Clin Breast Cancer. 2016;16(4):247-255.e3. https://doi.org/10.1016/j.clbc.2016.03.006
Heiney SP, Parker PD, Felder TM, Adams SA, Omofuma OO, Hulett JM. A systematic review of interventions to improve adherence to endocrine therapy. Breast Cancer Res Treat. 2019;173(3):499-510. https://doi.org/10.1007/s10549-018-5012-7
Michie S, Fixsen D, Grimshaw JM, Eccles MP. Specifying and reporting complex behaviour change interventions: the need for a scientific method. Implement Sci. 2009;4(1):40. https://doi.org/10.1186/1748-5908-4-40
Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81-95. https://doi.org/10.1007/s12160-013-9486-6
Michie S, Abraham C, Eccles MP, Francis JJ, Hardeman W, Johnston M. Strengthening evaluation and implementation by specifying components of behaviour change interventions: a study protocol. Implement Sci. 2011;6(1):10. https://doi.org/10.1186/1748-5908-6-10
Wright C, Barnett A, Campbell KL, Kelly JT, Hamilton K. Behaviour change theories and techniques used to inform nutrition interventions for adults undergoing bariatric surgery: a systematic review. Nutr Diet. 2022;79(1):110-128. https://doi.org/10.1111/1747-0080.12728
Talat U, Ann Schmidtke K, Khanal S, et al. A systematic review of nudge interventions to optimize medication prescribing. Front Pharmacol. 2022;13:25. www.frontiersin.org
Donovan G, Hall N, Ling J, Smith F, Wilkes S. Influencing medication taking behaviors using automated two-way digital communication: a narrative synthesis systematic review informed by the Behavior Change Wheel. Br J Health Psychol. 2022;27(3):861-890. https://doi.org/10.1111/bjhp.12580
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;10(1):372. https://doi.org/10.1186/s13643-021-01626-4
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-384. https://doi.org/10.1136/jech.52.6.377
Hooper P, Jutai JW, Strong G, Russell-Minda E. Age-related macular degeneration and low-vision rehabilitation: a systematic review. Can J Ophthalmol. 2008;43(2):180-187. https://doi.org/10.3129/i08-001
Silverman S, Schertz L, Yuen H, Lowman J, Bickel C. Systematic review of the methodological quality and outcome measures utilized in exercise interventions for adults with spinal cord injury. Spinal Cord. 2012;50(10):718-727. https://doi.org/10.1038/sc.2012.78
Bhandari S, Ngo P, Kute B, et al. Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study. Breast Cancer Res Treat. 2019;177(2):395-399. https://doi.org/10.1007/s10549-019-05308-7
Bluethmann SM, Truica C, Klepin HD, et al. Study design and methods for the using exercise to relieve joint pain and improve AI adherence in older breast cancer survivors (REJOIN) trial. J Geriatr Oncol. 2021;12(7):1146-1153. https://doi.org/10.1016/j.jgo.2021.05.011
Chalela P, Munoz E, Inupakutika D, et al. Improving adherence to endocrine hormonal therapy among breast cancer patients: study protocol for a randomized controlled trial. Contemp Clin Trials Commun. 2018;12:109-115. https://doi.org/10.1016/j.conctc.2018.10.001
Ell K, Vourlekis B, Xie B, et al. Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation. Cancer. 2009;115(19):4606-4615. https://doi.org/10.1002/cncr.24500
Graetz I, McKillop CN, Stepanski E, Vidal GA, Anderson JN, Schwartzberg LS. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial. J Cancer Surviv. 2018;12(4):431-440. https://doi.org/10.1007/s11764-018-0682-z
Hershman DL, Unger JM, Hillyer GC, et al. Randomized trial of text messaging to reduce early discontinuation of adjuvant aromatase inhibitor therapy in women with early-stage breast cancer: SWOG S1105. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(19):2122-2129. https://doi.org/10.1200/jco.19.02699
Krok-Schoen JL, Naughton MJ, Young GS, et al. Increasing adherence to adjuvant hormone therapy among patients with breast cancer: a smart phone app-based pilot study. Cancer Control. 2019;26(1):1073274819883287. https://doi.org/10.1177/1073274819883287
Lee C, Check DK, Manace Brenman L, et al. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020;180(1):219-226. https://doi.org/10.1007/s10549-020-05539-z
Meguerditchian A, Tamblyn R, Meterissian S, et al. Adjuvant endocrine therapy in breast cancer: a novel e-health approach in optimizing treatment for seniors (OPTIMUM): a two-group controlled comparison pilot study. JMIR Res Protoc. 2016;5(4):e199. https://doi.org/10.2196/resprot.6519
Mougalian SS, Epstein LN, Jhaveri AP, et al. Bidirectional text messaging to monitor endocrine therapy adherence and patient-reported outcomes in breast cancer. JCO Clin Cancer Informatics. 2017;1:1-10. https://doi.org/10.1200/cci.17.00015
Myers S, Weller S, Schwartz S, et al. Feasibility of a supervised virtual exercise program for women on hormone therapy for breast cancer. Transl J Am Coll Sport Med. 2022;7(4):e000213. https://doi.org/10.1249/tjx.0000000000000213
Paladino AJ, Anderson JN, Krukowski RA, et al. THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer. BMC Health Serv Res. 2019;19(1):977. https://doi.org/10.1186/s12913-019-4588-x
Ream ME, Walsh EA, Jacobs JM, et al. Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial. Breast Cancer Res Treat. 2021;190(1):79-88. https://doi.org/10.1007/s10549-021-06361-x
Sanft T, Harrigan M, Cartmel B, et al. Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: the Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: study protocol for a randomized clinical trial. Contemp Clin Trials. 2021;109:106508. https://doi.org/10.1016/j.cct.2021.106508
Shelby RA, Dorfman CS, Bosworth HB, et al. Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET). Contemp Clin Trials. 2019;76:120-131. https://doi.org/10.1016/j.cct.2018.11.010
Wagner VL, Jing W, Boscoe FP, Schymura MJ, Roohan PJ, Gesten FC. Improving adjuvant hormone therapy use in medicaid managed care-insured women, New York State, 2012-2014. Prev Chronic Dis. 2016;13(9):160185. https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994145026&doi=10.5888%2Fpcd13.160185&partnerID=40&md5=e1d7a6e285abd0913cb50a0fc5d5dc85
Arch JJ, Crespi CM, Levin ME, et al. Randomized controlled pilot trial of a low-Touch remotely-delivered values intervention to promote adherence to adjuvant endocrine therapy among breast cancer survivors. Ann Behav Med A Publ Soc Behav Med. 2022;56(8):856-871. https://doi.org/10.1093/abm/kaab118
Jacobs JM, Post K, Massad K, et al. A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: a randomized controlled trial. Cancer. 2022;128(19):3541-3551. https://doi.org/10.1002/cncr.34409
Yanez B, Oswald LB, Van Denburg AN, et al. Rationale and usability findings of an e-health intervention to improve oral anticancer adherence among breast cancer survivors: the My Journey mindfulness study. Contemp Clin Trials Commun. 2022;26:100898. https://doi.org/10.1016/j.conctc.2022.100898
Ferraris C, Ballestra B, Listorti C, et al. Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen. Breast Cancer Res Treat. 2020;180(1):157-165. https://doi.org/10.1007/s10549-020-05534-4
Hadji P, Blettner M, Harbeck N, et al. The Patient’s Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast canc. Ann Oncol Off J Eur Soc Med Oncol. 2013;24(6):1505-1512. https://doi.org/10.1093/annonc/mds653
Heisig SR, Shedden-Mora MC, von Blanckenburg P, et al. Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence. Psycho Oncol. 2015;24(2):130-137. https://doi.org/10.1002/pon.3611
Jacob L, Hadji P, Albert U.-S, Kalder M, Kostev K. Impact of disease management programs on women with breast cancer in Germany. Breast Cancer Res Treat. 2015;153(2):391-395. https://doi.org/10.1007/s10549-015-3530-0
Mamguem Kamga A, Di Martino C, Anota A, et al. Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial. Trials. 2020;21(1):527. https://doi.org/10.1186/s13063-020-04397-w
Moon Z, Moss-Morris R, Hunter MS, Goodliffe S, Hughes LD. Acceptability and feasibility of a self-management intervention for women prescribed tamoxifen. Health Educ J. 2019;78(8):901-915. https://doi.org/10.1177/0017896919853856
Riis CL, Jensen PT, Bechmann T, Möller S, Coulter A, Steffensen KD. Satisfaction with care and adherence to treatment when using patient reported outcomes to individualize follow-up care for women with early breast cancer - a pilot randomized controlled trial. Acta Oncol. 2020;59(4):444-452. https://doi.org/10.1080/0284186x.2020.1717604
Smith SG, Ellison R, Hall L, et al. Acceptance and Commitment Therapy to support medication decision-making and quality of life in women with breast cancer: protocol for a pilot randomised controlled trial. Pilot Feasibility Stud. 2022;8(1):33. https://doi.org/10.1186/s40814-022-00985-6
von Blanckenburg P, Schuricht F, Albert U.-S, Rief W, Nestoriuc Y. Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial. BMC Cancer. 2013;13(1):426. https://doi.org/10.1186/1471-2407-13-426
Ziller V, Kyvernitakis I, Knöll D, Storch A, Hars O, Hadji P. Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study. BMC Cancer. 2013;13(1):407. https://doi.org/10.1186/1471-2407-13-407
Markopoulos C, Neven P, Tanner M, et al. Does patient education work in breast cancer? Final results from the global CARIATIDE study. Future Oncol. 2015;11(2):205-217. https://doi.org/10.2217/fon.14.179
Getachew S, Addissie A, Seife E, et al. Breast nurse intervention to improve adherence to endocrine therapy among breast cancer patients in south Ethiopia. Oncol. 2022;27(8):e650-e660. https://doi.org/10.1093/oncolo/oyac081
Komatsu H, Yagasaki K, Yamaguchi T, et al. Effects of a nurse-led medication self-management programme in women with oral treatments for metastatic breast cancer: a mixed-method randomised controlled trial. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc. 2020;47:101780. https://doi.org/10.1016/j.ejon.2020.101780
Park HR, Kang HS, Kim SH, Singh-Carlson S. Effect of a smart pill bottle reminder intervention on medication adherence, self-efficacy, and depression in breast cancer survivors. Cancer Nurs. 2021;45(6):E874-E882. https://doi.org/10.1097/ncc.0000000000001030
Tan EH, Wong ALA, Tan CC, et al. Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: a randomised controlled trial to evaluate the effect of short message service (SMS) reminder. Breast. 2020;53:77-84. https://doi.org/10.1016/j.breast.2020.06.012
Yu K.-D, Zhou Y, Liu G.-Y, et al. A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer. Breast Cancer Res Treat. 2012;134(1):307-313. https://doi.org/10.1007/s10549-012-2059-8
Yu J, Wu J, Huang O, Chen X, Shen K. A smartphone-based app to improve adjuvant treatment adherence to multidisciplinary decisions in patients with early-stage breast cancer: observational study. J Med Internet Res. 2021;23(9):e27576. https://doi.org/10.2196/27576
Bandura A. Health promotion from the perspective of social cognitive theory. Psychol Heal. 1998;13(4):623-649. https://www.tandfonline.com/doi/abs/10.1080/08870449808407422
Antoni MH. Stress management for women with breast cancer. In: Stress management intervention for women with breast cancer. American Psychological Association; 2004:7-50.
Mann E, Smith MJ, Hellier J, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012;13(3):309-318. https://doi.org/10.1016/s1470-2045(11)70364-3
Safren S, Gonzalez J, Soroudi N. Coping with Chronic Illness: A Cognitive-Behavioral Approach for Adherence and Depression. Oxford University Press; 2007:144. https://books.google.com/books/about/Coping_with_Chronic_Illness.html?hl=it&id=F3D1vgEACAAJ
Jordan JL, Ellis SJ, Chambers R. Defining shared decision making and concordance: are they one and the same? Postgrad Med J. 2002;78(921):383-384. https://doi.org/10.1136/pmj.78.921.383
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211. https://doi.org/10.1016/0749-5978(91)90020-t
Becker MH, Drachman RH, Kirscht JP. A new approach to explaining sick-role behavior in low-income populations. Am J Public Health. 1974;64(3):205-216. https://doi.org/10.2105/ajph.64.3.205
Leventhal H, Phillips LA, Burns E. The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management. J Behav Med. 2016;39(6):935-946. https://doi.org/10.1007/s10865-016-9782-2
Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1-25. [Internet] [cited 2022 Dec 22]. https://doi.org/10.1016/j.brat.2005.06.006
Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985;8(2):163-190. [Internet] [cited 2022 Dec 22]. https://doi.org/10.1007/bf00845519
Steele CM. The psychology of self-affirmation: sustaining the integrity of the self. Adv Exp Soc Psychol. 1988;21(C):261-302.
Waks AG, Winer EP. Breast cancer treatment: a review. JAMA, J Am Med Assoc. 2019;321(3):288-300. https://doi.org/10.1001/jama.2018.19323
Penedo FJ, Oswald LB, Kronenfeld JP, Garcia SF, Cella D, Yanez B. The increasing value of eHealth in the delivery of patient-centred cancer care. Lancet Oncol. 2020;21(5):e240-e251. https://doi.org/10.1016/s1470-2045(20)30021-8
Kondylakis H, Bucur A, Dong F, et al. IManageCancer: developing a platform for empowering patients and strengthening self-management in cancer diseases. Proc - IEEE Symp Comput Med Syst. 2017:755-760.
Kondylakis H, Koumakis L, Tsiknakis M, et al. Smart recommendation services in support of patient empowerment and personalized medicine. Smart Innov Syst Technol. 2013;25:39-61. https://link.springer.com/chapter/10.1007/978-3-319-00375-7_4
Kondylakis H, Koumakis L, Genitsaridi E, et al. IEmS: a collaborative environment for patient empowerment. IEEE 12th Int Conf Bioinforma Bioeng BIBE. 2012:535-540.
Humphreys G, Evans R, Makin H, Cooke R, Jones A. Identification of behavior change techniques from successful web-based interventions targeting alcohol consumption, binge eating, and gambling: systematic review [Internet]. J Med Internet Res. 2021;23(2):e22694. [cited 2022 Dec 20. https://doi.org/10.2196/22694
Schembre SM, Liao Y, Robertson MC, et al. Just-in-time feedback in diet and physical activity interventions: systematic review and practical design framework [Internet]. J Med Internet Res. 2018;20(3):e106. [cited 2022 Dec 20]. https://doi.org/10.2196/jmir.8701
McGrady ME, Schwartz LE, Noser AE, et al. Systematic evaluation of the behavior change techniques and quality of commercially available cancer self-management apps. JCO Oncol Pract. 2022. [Internet][cited 2022 Dec 20]; https://pubmed.ncbi.nlm.nih.gov/36446046/
Atkins L, Fallowfield L. Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer. 2006;42(14):2271-2276. https://doi.org/10.1016/j.ejca.2006.03.004